EE577 Early Initiation of Guselkumab Increases Duration of Complete Remission (Psoriasis Area and Severity Index 100) in Patients With Moderate-to-Severe Psoriasis
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.842
https://www.valueinhealthjournal.com/article/S1098-3015(23)03972-4/fulltext
Title :
EE577 Early Initiation of Guselkumab Increases Duration of Complete Remission (Psoriasis Area and Severity Index 100) in Patients With Moderate-to-Severe Psoriasis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03972-4&doi=10.1016/j.jval.2023.09.842
First page :
Section Title :
Open access? :
No
Section Order :
10335